memantine

(redirected from Axura)
Also found in: Medical.

me·man·tine

 (mə-măn′tēn)
n.
A drug, C20H24N5O4, used in its hydrochloride form to treat symptoms of Alzheimer's disease by inhibiting NMDA receptors.

[me(thyl) + (ada)mant(ane), molecule with a diamond-like structure (from Greek adamās, adamant-, diamond; see adamant) + -ine.]
Translations

memantine

n memantina
References in periodicals archive ?
Mobius, chief scientific officer of Merz Pharmaceuticals, a Germany company that holds the licensing rights to memantine and also markets the drug as Axura in several countries.
Mobius, chief scientific officer of Merz Pharmaceuticals, a Germany firm that holds the licensing rights to memantine and markets the drug as Axura in several countries.
These therapies include the acetylcholinesterase inhibitors (AChEIs)--Eisai/Pfizer's Aricept (donepezil, generics), Shire/Janssen-Cilag's Reminyl/Reminyl LP (galantamine/galantamine ER, generics), and Novartis's Exelon (rivastigmine, generics) and Exelon Patch (rivastigmine transdermal)--and the NMDA receptor antagonist memantine (Merz Pharmaceuticals/Grunenthal's Axura and Lundbeck's Ebixa).